Latest News about AZN
Recent news which mentions AZN
Earnings Scheduled For February 10, 2022
February 10, 2022
From Benzinga
Down 52% In 3 Months, Is Moderna Stock a Bargain Buy?
February 09, 2022
From Motley Fool
Take a Leap Into Novavax Stock After Vaccine Sales Start
February 08, 2022
From InvestorPlace
EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.
February 08, 2022
From InvestorPlace
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
February 08, 2022
From Motley Fool
From Benzinga
New Jersey Gov. Murphy to scrap student face mask mandates in March, and Ottawa declares emergency over trucker protest
February 07, 2022
Tickers
AZN
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
3 Biotech Stocks That Could Make You Richer in February (and Beyond)
February 05, 2022
From Motley Fool
AstraZeneca Dumps Off Mid-Stage Cardiovascular Drug To Regio Biosciences
February 03, 2022
From Benzinga
4 Great Global Stocks to Buy for a Diversified Portfolio
February 03, 2022
From InvestorPlace
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
From InvestorPlace
7 Stocks to Watch in This Current Earnings Season
February 01, 2022
From InvestorPlace
The sector investors are ignoring in one of the year’s best performing global markets
January 31, 2022
From MarketWatch
From Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
From Benzinga
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
January 24, 2022
From Benzinga
From Benzinga
3 Unstoppable Biotech Stocks to Buy Right Now
January 24, 2022
From Motley Fool
From Benzinga
7 Bull Market Stocks to Buy for a Continued Run Higher in 2022
January 20, 2022
From InvestorPlace
7 Bear Market Stocks to Buy If You See Trouble Ahead
January 20, 2022
From InvestorPlace
Is Ocugen Stock a Buy Now?
January 20, 2022
From Motley Fool
AstraZeneca Rolls Out "Unprecedented' Three Year Survival Data For Imfinzi/Treme Combo In Liver Cancer
January 19, 2022
From Benzinga
3 Under-the-Radar COVID Stocks
January 19, 2022
From Motley Fool
Here's Some Good News for Novavax That Investors Are Overlooking
January 18, 2022
From Motley Fool
This Could Be Another Blockbuster Indication for AstraZeneca
January 17, 2022
Tickers
AZN
From Motley Fool
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
January 16, 2022
From Benzinga
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.